Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (271-280 of 635) with videos related to

Pageof 64
Sort By:
American Heart Journal|June 12, 2020
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Larry R Jackson, Sunghee Kim, Rosalia Blanco, et al.
The American Journal of Cardiology|January 31, 2007
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)Melvin R Echols, Kenneth W Mahaffey, Anindita Banerjee, et al.
American Heart Journal|March 21, 2016
Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation RegistryHarsh Golwala, Larry R Jackson, DaJuanicia N Simon, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2024
Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical TrialHiddo J L Heerspink, Vlado Perkovic, Katherine R Tuttle, et al.
Circulation. Cardiovascular Interventions|March 16, 2019
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y<sub>12</sub> Inhibitor PretreatmentJeremie Abtan, Gregory Ducrocq, Philippe Gabriel Steg, et al.
American Heart Journal|March 23, 2019
Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillationMalini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Circulation. Cardiovascular Imaging|January 13, 2025
Abnormal Exercise Electrocardiography With Normal Stress Echocardiography Is Associated With Subclinical Coronary AtherosclerosisJessica M Duran, Peter Shrader, Chuan Hong, et al.
The New England Journal of Medicine|December 14, 2016
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery DiseaseWilliam R Hiatt, F Gerry R Fowkes, Gretchen Heizer, et al.
Circulation|October 19, 2016
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product LabelingSean D Pokorney, Peter Shrader, Laine Thomas, et al.
Circulation|April 1, 2014
Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
Pageof 64

Showing results (271-280 of 635) with videos related to

Sort By:
Pageof 64
American Heart Journal|June 12, 2020
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)Larry R Jackson, Sunghee Kim, Rosalia Blanco, et al.
The American Journal of Cardiology|January 31, 2007
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)Melvin R Echols, Kenneth W Mahaffey, Anindita Banerjee, et al.
American Heart Journal|March 21, 2016
Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation RegistryHarsh Golwala, Larry R Jackson, DaJuanicia N Simon, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2024
Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical TrialHiddo J L Heerspink, Vlado Perkovic, Katherine R Tuttle, et al.
Circulation. Cardiovascular Interventions|March 16, 2019
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y<sub>12</sub> Inhibitor PretreatmentJeremie Abtan, Gregory Ducrocq, Philippe Gabriel Steg, et al.
American Heart Journal|March 23, 2019
Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillationMalini Madhavan, DaJuanicia N Holmes, Jonathan P Piccini, et al.
Circulation. Cardiovascular Imaging|January 13, 2025
Abnormal Exercise Electrocardiography With Normal Stress Echocardiography Is Associated With Subclinical Coronary AtherosclerosisJessica M Duran, Peter Shrader, Chuan Hong, et al.
The New England Journal of Medicine|December 14, 2016
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery DiseaseWilliam R Hiatt, F Gerry R Fowkes, Gretchen Heizer, et al.
Circulation|October 19, 2016
Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product LabelingSean D Pokorney, Peter Shrader, Laine Thomas, et al.
Circulation|April 1, 2014
Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
Pageof 64